315 results on '"Abdulkadir, Sarki A."'
Search Results
2. Inflammatory bowel disease induces inflammatory and pre-neoplastic changes in the prostate
3. ‘Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting
4. Pleckstrin-2 Mediates the Activation of AKT in Prostate Cancer and Is Repressed by Androgen Receptor
5. Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC
6. Association between inflammatory bowel disease and prostate cancer: A large‐scale, prospective, population‐based study
7. Genomic Profiling of Prostate Cancers from Men with African and European Ancestry
8. A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer
9. Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2–ERG fusions
10. A surrogate molecular approach for the detection of Philadelphia chromosome–like B‐acute lymphoblastic leukemia.
11. A surrogate molecular approach for the detection of Philadelphia chromosome–like B‐acute lymphoblastic leukemia
12. ALL-205 Deconvoluting and Characterizing the Newly Incorporated Genetic Subtypes and Treatment Outcomes of Acute Lymphoblastic Leukemia: A Report of 1,021 Indian Patients 5-Year Study
13. POSTER: ALL-205 Deconvoluting & Characterizing the Newly Incorporated Genetic Subtypes & Treatment Outcomes of Acute Lymphoblastic Leukemia: A Report of 1,021 Indian Patients 5-Year Study
14. Prostate Stroma Increases the Viability and Maintains the Branching Phenotype of Human Prostate Organoids
15. HYbrid DegRAding Copolymer (HYDRAC): Heterobifunctional polymers for targeted degradation of undruggable proteins.
16. Correction: Inflammatory bowel disease induces inflammatory and preneoplastic changes in the prostate
17. Targeting FOXAI-mediated repression of TGF-[beta] signaling suppresses castration-resistant prostate cancer progression
18. Overcoming immunosuppression in bone metastases
19. Abstract 2714: Inhibiting Myc using heterofunctional polymeric degrading chimeras (HYDRACs): a novel class of compounds capable of targeted protein degradation
20. Data from Activated ALK Cooperates with N-Myc via Wnt/β-Catenin Signaling to Induce Neuroendocrine Prostate Cancer
21. Supplementary Table S2 from Activated ALK Cooperates with N-Myc via Wnt/β-Catenin Signaling to Induce Neuroendocrine Prostate Cancer
22. Figure S1, Figure S2, Table S1 from Anaplastic Lymphoma Kinase Mutation (ALK F1174C) in Small Cell Carcinoma of the Prostate and Molecular Response to Alectinib
23. Supplementary Figures 1 - 3 from RNAi Screen Identifies a Synthetic Lethal Interaction between PIM1 Overexpression and PLK1 Inhibition
24. Supplementary Table from A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate Cancer
25. Supplementary Figures from Genomic Profiling of Prostate Cancers from Men with African and European Ancestry
26. Figure S2 from Genomic Profiling of Prostate Cancers from Men with African and European Ancestry
27. Data from A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate Cancer
28. Supplementary Tables 1-22 from Genomic Profiling of Prostate Cancers from Men with African and European Ancestry
29. Supplementary Data from A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate Cancer
30. Supplementary Information from Activated ALK Cooperates with N-Myc via Wnt/β-Catenin Signaling to Induce Neuroendocrine Prostate Cancer
31. Supplementary Data from Activated ALK Cooperates with N-Myc via Wnt/β-Catenin Signaling to Induce Neuroendocrine Prostate Cancer
32. EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cells
33. Hematological, clinical, immunophenotypic characterization, and treatment outcomes of prognostically significant genetic subtypes of B‐lineage acute lymphoblastic leukemia: A report of 1021 patients from India.
34. Abstract LB082: Genome-wide CRISPR activation screen identifies PRRX2 as an enzalutamide resistance gene in prostate cancer
35. Development of heterobifunctional proteomimetic polymers for delivery of MYC inhibitory peptides and targeted MYC degradation.
36. Decreased mitochondrial SIRT3 expression is a potential molecular biomarker associated with poor outcome in breast cancer
37. RAMP1 Is a Direct NKX3.1 Target Gene Up-Regulated in Prostate Cancer that Promotes Tumorigenesis
38. A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression
39. A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate Cancer
40. A phase II study of sEphB4-HSA in metastatic castration-resistant prostate cancer.
41. 'Impact of ICT for the 21st Century: A Change Driving Tools for Tertiary Education in Nigeria'
42. Advanced glycation end‐products (AGEs) are lower in prostate tumor tissue and inversely related to proportion of West African ancestry
43. PIM Kinase Inhibitor AZD1208 for Treatment of MYC-Driven Prostate Cancer
44. The Major Histocompatibility Complex Genes and their Transcriptional Regulation
45. SIRT3 Is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integrity and Metabolism during Stress
46. Correction: Inflammatory bowel disease induces inflammatory and preneoplastic changes in the prostate
47. Inhibition of NF-AT-Dependent Transcription by NF-κB: Implications for Differential Gene Expression in T Helper Cell Subsets
48. Inflammatory bowel disease induces inflammatory and pre-neoplastic changes in the prostate
49. Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer
50. Activated ALK Cooperates with N-Myc via Wnt/β-Catenin Signaling to Induce Neuroendocrine Prostate Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.